Skip to content

MODO MEDICAL

Active
Private limited companyfounded 2014active for 12 yearsAvenue Emile Verhaeren 13, 1300 Wavre, BelgiumKBO/BCE: BE 0561.730.661
Summary

MODO MEDICAL has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.5m and a net result of €184,873. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 86% of 19,741 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Specialist medical practice
NACE 86220
5th largest company by equity in Wavre, Health and social work sector1 site
Size
≈ €420,000turnover 2024, estimated
Staff
≈ 0.4 FTE, estimated
Equity
€1.5m
Profit
€184,873
Turnover estimated from the gross margin
Financial health
55 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.8%
Structure
2025 accounts not filed, 89 days past the deadline2 of 3 deeds summarised
Why 55raises riskCapped at 59: a confirmed filing findingLiquidity: current ratio 14.21, cash €9,267Figures for financial year 2024 (filed 01-10-2025)1 financial year not filed after the legal deadline; last filed accounts filed 61 days late; 3 of the last 3 latelowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2024
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 48% of its sector peers (NACE 86, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Strong
Solvency 100=
equity 92.2% of total assets
Liquidity 51=
short-term debt 6.9% · cash 0.6%
Profitability 83=
return on assets 11.3%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)
Last 24 months 11-2024: 1.9% 12-2024: 2.2%▲ +0.3 percentage points vs 11-2024 01-2025: 3.3%▲ +1.1 percentage points vs 12-2024 02-2025: 3.2%▼ -0.1 percentage points vs 01-2025 03-2025: 3.1%▼ -0.1 percentage points vs 02-2025 04-2025: 2.9%▼ -0.2 percentage points vs 03-2025 05-2025: 2.9%● unchanged vs 04-2025 06-2025: 2.9%● unchanged vs 05-2025 07-2025: 2.9%● unchanged vs 06-2025 08-2025: 4.1%▲ +1.2 percentage points vs 07-2025 09-2025: 4.2%▲ +0.1 percentage points vs 08-2025highest value 10-2025: 2.0%▼ -2.2 percentage points vs 09-2025 11-2025: 0.2%▼ -1.8 percentage points vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025lowest value 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.4%▲ +0.2 percentage points vs 07-2026 09-2026: 0.5%▲ +0.1 percentage points vs 08-2026 10-2026: 0.8%▲ +0.3 percentage points vs 09-2026
Credit of up to €80,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity ample (current ratio 14.21, compared with 12.43 in 2023, above the usual 1.5; short-term debt: 6.9% and cash: 0.6% of total assets), and 7.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 23% on liquidity, 31% on profitability and 57% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Liquidity: current ratio 14.21, cash €9,267
NBB · annual accounts
raises risk · Figures for financial year 2024 (filed 01-10-2025)
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 financial year not filed after the legal deadline; last filed accounts filed 61 days late; 3 of the last 3 late
NBB · filings
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 89 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline28-10-2026 today
raises risk · 2024 accounts filed 61 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
61 days late
2023
419 days late
2022
338 days late
2021
122 days late
2020
153 days late
2019
151 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 207 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Andrei DOLJENCU (director)Director discharge
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Key points

  • Positive: Among the best 5% on equitysector median €148,119 · 19,745 companies €1.5m View
  • Caution: 2025 accounts not fileddeadline was 31-07-2026 89 days past the deadline View
  • Positive: 7 profitable years in a rowprofit 2024: €184,873 7 years View

By topic

Financials

Financial year
2024
Total assets
€1.6m
Profit
€184,873
Solvency
92.2%
Go to Financials

Timeline

Events
14
Since
2016
  1. 06-08-2025Reappointments: MOTOSAN Claudia (director) and DOLJENCU Andrei…
  2. 03-07-2024Annual accounts filed
  3. 30-11-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
14-08-2014
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
45
Who signs
Each director alone
Annual meeting
First Thursday of May
Purpose
“L'exercice, en son nom et pour son compte, de la médecine, plus précisément la chirurgie…” (deed in French)
Go to Articles of association

Key facts about MODO MEDICAL

What is the company number of MODO MEDICAL?
0561.730.661. In Belgium the VAT number is the company number with BE in front: BE 0561.730.661.
Where is MODO MEDICAL based?
The registered office is at Avenue Emile Verhaeren 13, 1300 Wavre.Company details
What does MODO MEDICAL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MODO MEDICAL?
Private limited company (BV).
When was MODO MEDICAL founded?
On 14-08-2014.
Is MODO MEDICAL still active?
Yes, MODO MEDICAL is an active enterprise in the KBO register.
How many employees does MODO MEDICAL have?
On average 0.9 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
What is the turnover of MODO MEDICAL?
€415,112 in financial year 2018, according to the filed annual accounts.
Is MODO MEDICAL profitable?
In financial year 2024, MODO MEDICAL made a profit of €184,873.
Where can I find the annual accounts of MODO MEDICAL?
MODO MEDICAL filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Companies related to MODO MEDICAL

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.